Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The FDA “likes” it.
Products4Doctors
https://onetouchtelemed.com
TESTING COVID-19
DxAllergy now offers a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) blood test based on advanced Silicon Valley technology and finger stick blood collection. Deposit a few drops of patient blood on our blood card collection device, express mail your cards to our laboratory and receive definitive test results for the presence of immunoglobulin G (IgG) antibodies reactive to SARS-CoV-2 proteins.
Dr. Anthony Fauci – well known director of the National Institute of Allergy and Infectious Disease, has recently emphasized the importance of differentiating Covid-19 symptoms from those of seasonal allergies.
Accordingly, from the same blood sample we test for 120 common seasonal environmental and non-environmental/food allergies.
This combined COVID-19 / 120 allergen panel test protocol provides an unprecedented definitive and actionable respiratory health profile. The extreme sensitivity of the test can detect virus in most cases earlier that the nasopharyngeal swab test. This test protocol can be administered to any patient regardless of symptoms and is covered by insurance.
• Patients who have been sick and are no longer symptomatic, a positive IgG indicates that they have had the virus.
• Patients that are symptomatic and show a positive IgG the indication is that they have currently active virus
• Patients who are IgG negative but show active environmental allergies, COVID-19 can likely be ruled out.
Test in office or Telemedicine for COVID-19
We are offering COVID-19 testing using a blood drop sample
Results in 48 hours on Portal — Covered by all insurance — no costs involved for testing
No Cost Testing Only Lab On-Boarding Form Below
https://www.patientdatasolutions.com/signup/ek7774/
Easily test all your patients for COVID-19 from their home
Your practice can utilize our televideo format that is linked directly to the lab making it simple to submit the requisition.
A practice will order testing sent to the home of a patient and the patient will do a finger prick blood test and send sample to lab in a prepaid overnight envelope Using televideo you will be able to bill using the same CPT code as an office visit The practice will get 2 visits from this process initial televideo visit and the follow up Something to think about you can turn those phone calls you take after hours and make them abillable event under the same CPT code as if the patient were in your office using TeleVideo.
DxAllergy Solutions on Twitter
10/16/19
“ Dxallergy Solutions, named US Master distributor for Arrayit corporation.
Dxallergy.com website now live. #1 fastest growing allergy/immunotherapy program in America”
Agreed
(ii) Fewer than 500 persons, where the total assets of the issuer have not exceeded $10 million on the last day of.....each of the issuer's three most recent fiscal years...
It may not be able to be quoted...but it is trading. Good buy!
TDA has 1.3 million in volume. And this was never supposed to trade again! Dead! Dead! Dead!
So WRONG!!!
“Arrayit” on that envelope. Nice.
UPDATE April 21, 2020 - SARS-CoV-2 (COVID-19) TEST
As of this date, our CLIA laboratory had notified the FDA that it had validated, and is now offering, their COVID-19 test under the FDA’s guidelines, “Policy for Diagnostic Tests for Coronavirus Disease 2019.” Our laboratory is now offering this test while we await an official EUA status letter from the FDA. Our COVID-19 test measures IgG reactions to 12 epitomes (proteins) that are specific to COVID-19.
https://antibodycovidtest.com/
And we all knew they had a test. Because they told us so.
Thanks for the posts MikeCr and jhols.
I'm Jason Nielsen.
Mark and I went to school together.
I was dating Rene at the time...
Up 17% pre-market...now 20%
Wow, again!
“Hospital Revenue Specialist”
Seems to be one gentleman representing Hospital Vertical Partners...
Great update. Looks like this doc is going to be revised as updates are available.
Great to know Arrayit is letting the world know about their abilities to stem this pandemic through their distributorships.
“This applies to all 1,400 clinics in the United States that offers the COVID-19 Antibody Screen in addition to the Allergy Test.
"Arrayit believes it is an important test to make available and wants the patients to be able to make an informed decision on the test should they decide to take it. Arrayit is using the news piece as a breeder document to help educate the Clinics offering the test.”
ROCK ON!!
Contact US help@antibodycovidtest.com or Covid19antibodytest@gmail.com
Copyright © 2020 Covid -19 Antibody Test - All Rights Reserved.
Cole Business Development LLC (Louisiana LLC) operates within a Master Services Agreement with Arrayit Corporation, Sunnyvale California for State Licensed, CLIA certified clinical testing services.Registrations of Federal, State Government and all properly licensed healthcare providers are provided through Arrayit Corporation partner Patient Data Solutions.
My pleasure, just happened to be the one to see it.
I just happened to watch it again and saw the Friday update with the response from Dr. Haje.
Riding on your coat-tails...good find yourself.
Yes, surprised me. Arrayit has been growing it’s distributorship just like we’d hoped for.
On Friday, Haje sent Action News Jax the following statement:
“Thank you for the fair and unbiased reporting.
"As a result of your good work, Arrayit has put a review process in place to examine the messaging and educate the Clinics on how to properly communicate to their patient base. Arrayit has assigned an Executive with a degree in Journalism to conduct the reviews.
"This applies to all 1,400 clinics in the United States that offers the COVID-19 Antibody Screen in addition to the Allergy Test.
"Arrayit believes it is an important test to make available and wants the patients to be able to make an informed decision on the test should they decide to take it. Arrayit is using the news piece as a breeder document to help educate the Clinics offering the test.
"Thank you for your work and bringing this to our attention, these are scary times and precise and accurate reporting is critical for all of us, your viewers”
https://www.actionnewsjax.com/news/local/duval-county/action-news-jax-investigates-jacksonville-chiropractors-claims-surrounding-allergy-testing-that-also-detects-covid-19/BBXPEAWWQVEXVBMZ6M7IWBDHLA/?_website=cmg-tv-10050
I think they responded well to the questions in that article.
Arrayit is going to be “The Knight in Shining Armor” in gaining the understanding of the full breath of this pandemic.
This is going to be so big! HUGE!
It looks like the site has been compromised since last night.
Telemedicine with Diagnostics/COVID
A telemedicine platform that leverages respiratory testing for allergies and COVID19. The platform is quick and easy to setup and works for any practice type. Telemedicine is needed NOW. Doctors need to see their patients and don't want them coming to their practice needlessly. Patients presenting with respiratory problems can be sent a Fingerstick Test blood that will do a 120 allergen test panel PLUS a COVID test.
https://everyancillary.com/ancillary-listing/telemedicine-with-diagnostics-covid/
Phone numbers are the same...
Patient Data Solutions
408-898-1400
TECH SUPPORT 408-898-1400
Taub has no evidence of damages. They couldn’t even prove damages in their own motion for summary judgment. It was slapped down by the judge. This is the second and last time that they have failed to prove damages.
“Because Plaintiffs fail to sufficiently demonstrate actual damages as to the filing of the registration statement and the issuance of the convertible promissory notes, Plaintiffs’ motion for reconsideration is DENIED as to these claims.”
No damages of any kind. Where do you get the $680k? That doesn’t exist in the order.
“As a preliminary matter, Plaintiffs’ argument concerning the viability of a damages
defense is incorrect and contradicted by Seventh Circuit precedent interpreting contracts arising
under Illinois law. See TAS Distrib. Co., 491 F.3d at 631. To succeed on their motion for
summary judgment, Plaintiffs must put forth some evidence showing it suffered actual damages.
Here, the record does contain evidence of actual damages as it relates to Defendants’ failure to
contribute the Products and to issue, amend or double warrants and shares. For example,
Plaintiffs did not receive the Products, which their damages expert estimated was worth
$20,550,000. Pl.’s Ex. Y at 1, ECF No. 171. Further, Plaintiff Zalcberg did not receive the 5
million shares, which Plaintiffs damages expert estimated was worth $780,000. Id.
However, Plaintiffs do not identify any evidence of actual damages as it relates to
Defendants’ failure to file the registration statement nor Defendants’ issuance of convertible
debentures. Concerning the latter, Plaintiffs simply allege “[D]efendants executed convertible
promissory notes totaling over $600,000, precipitating a calamitous drop of the Company’s stock
price,” Pl. Br. at 8; but, they do not specifically identify any evidence demonstrating a price
decrease. Accordingly, Plaintiffs satisfy the elements of a breach of contract claim as to the
obligations to contribute the Product and to issue, double, and modify warrants and stocks; hence
Plaintiffs’ motion for summary judgment is GRANTED as to these claims. Because Plaintiffs
fail to sufficiently demonstrate actual damages as to the filing of the registration statement and
the issuance of the convertible promissory notes, Plaintiffs’ motion for reconsideration is
DENIED as to these claims.”
https://www.courtlistener.com/docket/6441913/194/taub-v-arrayit-corporation/
Looks like Taub can continue to court for breach of contract but not for damages due to breach of contract. And Arrayit’s counter claim for lack of funding by Taub is denied.
https://www.courtlistener.com/docket/6441913/194/taub-v-arrayit-corporation/
Thanks so much for sharing such great info. Much appreciated.
BOOM CHAKALAKA!
List of other Arrayit Corp Customers
Government Laboratories
Centers for Disease Control
Veterans Administration Medical Center
SAIC
West Point Military Academy
Sandia National Laboratory
Commonwealth Scientific and Industrial Research Organization (CSIRO)
Infectious Disease Research Institute
National Institutes of Health
Virginia Biosciences Community
Lawrence Berkeley National Laboratory
Pharma/Diagnostics
Genesis Diagnostics Ltd
Excelsior Bio-Systems Inc
Eventus Dx
Progenika Biopharma
Belmedtechnika
Ibis Bioscience/Abbott Laboratories
Opko Pharma
Baxter Healthcare
Natrix Lab
Perkin Elmer Life Sciences
Life Science/Biotech
European Biotech Network
VWR International
SIC Vita S
Wallac Oy
Molecular Devices UK Ltd.
Gene Company
ChemBio
Polgen
Research Biolabs Pte Ltd
Digilab
University Laboratories
University of Texas Southwestern Medical Center
University of Illinois
Monash University
University of Oklahoma
University of California, Davis
Arizona State University
Stanford University
University of Arizona
University of California, San Diego
Texas Tech
https://www.prnewswire.com/news-releases/genentech-purchases-arrayit-technology-223112431.html
I believe the end date was 2020 and looks to have been extended.
Research Project: Molecular Identification and Characterization of Bacterial and Viral Pathogens Associated with Foods
Location: Produce Safety and Microbiology Research
Project Number: 2030-42000-051-00-D
Project Type: In-House Appropriated
Start Date: Feb 25, 2016
End Date: Feb 24, 2021
“Early microarray fabrication technologies employed photolithography, as used by Affymetrix, or pin technology championed by their academic inventors and proponents, both described in now famous articles published in Science by Steven Fodor et al (24) and Mark Schena et al (25), respectively.”
9. Martinsky, T. (2003) Printing technologies and microarray manufacturing techniques: making the perfect microarray, in Blalock, E. (ed) A beginner's guide to microarrays, Kluwer Academic Publishers, Norwell.
25. Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray, Science 270, 467-470.
Deal with it......or don’t.
Don’t be a cry-baby.
The only reality is they ceased doing business with each other. The reason is not known. So don’t make up a fake one.
Faaaaaake Neewwws!!!!!!! Screenshot required!!